Drugs / Influenza virus vaccine (2004-2005 Formulation)
Influenza virus vaccine (2004-2005 Formulation)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00858468 | Apr 2005 → Jun 2006 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza virus vaccine (2004-2005 Formulation) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00858468 ↗ |
| Modality | Vaccine | “inactivated, split-virion influenza vaccine” NCT00858468 ↗ |
| Route | Intramuscular | “0.25 mL, Intramuscular” NCT00858468 ↗ |